litlas
Log inCreate account

Robert W. Coombs

Active 1987–2025

94
Papers
24,001
Citations
73
h-index
93
i10-index

Citations

Citations per year for Robert W. Coombs1986: 1 citations1988: 3 citations1989: 5 citations1990: 21 citations1991: 48 citations1992: 42 citations1993: 44 citations1994: 29 citations1995: 56 citations1996: 121 citations1997: 161 citations1998: 237 citations1999: 180 citations2000: 200 citations2001: 128 citations2002: 117 citations2003: 105 citations2004: 115 citations2005: 117 citations2006: 93 citations2007: 121 citations2008: 133 citations2009: 101 citations2010: 161 citations2011: 147 citations2012: 130 citations2013: 151 citations2014: 184 citations2015: 140 citations2016: 133 citations2017: 74 citations2018: 80 citations2019: 362 citations2020: 313 citations2021: 248 citations2022: 337 citations2023: 217 citations2024: 307 citations2025: 96 citations2026: 2 citations1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,886 citing papers, 39.8% of this breakdownUnited Kingdom: 542 citing papers, 7.5% of this breakdownSouth Africa: 374 citing papers, 5.2% of this breakdownCanada: 263 citing papers, 3.6% of this breakdownFrance: 228 citing papers, 3.1% of this breakdownKenya: 193 citing papers, 2.7% of this breakdownSwitzerland: 175 citing papers, 2.4% of this breakdownChina: 175 citing papers, 2.4% of this breakdownGermany: 157 citing papers, 2.2% of this breakdownItaly: 157 citing papers, 2.2% of this breakdownAustralia: 149 citing papers, 2% of this breakdownUganda: 145 citing papers, 2% of this breakdown
0%39.8%Other 24.9%

Institutions

Fields

  • Medicine62.1%
  • Immunology and Microbiology28.6%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Social Sciences1.2%
  • Health Professions1.2%
  • Mathematics0.8%
  • Other2.8%

Topics

  • HIV/AIDS Research and Interventions16.9%
  • HIV Research and Treatment14.4%
  • HIV/AIDS drug development and treatment9.3%
  • HIV, Drug Use, Sexual Risk4.2%
  • HIV-related health complications and treatments3.7%
  • Adolescent Sexual and Reproductive Health3.3%
  • Other48.2%

Coauthors

All papers

Open in search
  1. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

    Authors: Jared M. Baeten, Deborah Donnell, Patrick Ndase, Nelly Mugo, James D. Campbell, Jonathan Wangisi, Jordan W. Tappero, Elizabeth A. Bukusi, Craig R. Cohen, Elly Katabira, Allan Ronald, Elioda Tumwesigye, Edwin Were, Kenneth H. Fife, James Kiarie, Carey Farquhar, Grace John‐Stewart, Aloysious Kakia, Josephine Odoyo, Akasiima Mucunguzi, Moses Joloba, Rogers Twesigye, Kenneth Ngure, Cosmas Apaka, H Tamooh, Fridah Gabona, Andrew Mujugira, Dana Panteleeff, Katherine K. Thomas, Lara Kidoguchi, Meighan Krows, Jennifer Revall, Susan Morrison, Harald S. Haugen, Mira Emmanuel-Ogier, Lisa Ondrejcek, Robert W. Coombs, Lisa M. Frenkel, Craig W. Hendrix, Namandjé N. Bumpus, David R. Bangsberg, Jessica E. Haberer, Wendy Stevens, Jairam R. Lingappa, Connie Celum - New England Journal of Medicine 2012 cited by 3,309

  2. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

    Authors: Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay, Germán Áñez, Jeffrey Adelglass, Alejandro Quintín Barrat Hernández, Wayne L. Harper, Daniel M. Duncanson, Monica A. McArthur, Diana F. Florescu, R. Scott McClelland, Veronica Garcia-Fragoso, Robert Riesenberg, David B. Musante, David L. Fried, Beth Safirstein, Mark McKenzie, Robert Jeanfreau, Jeffrey K. Kingsley, Jeffrey A. Henderson, Dakotah C. Lane, Guillermo M. Ruiz‐Palacios, Lawrence Corey, Kathleen M. Neuzil, Robert W. Coombs, Alexander L. Greninger, Julia Hütter, Julie A. Ake, Katherine R. Smith, Wayne Woo, Iksung Cho, Gregory M. Glenn, Filip Dubovsky - New England Journal of Medicine 2021 cited by 453

  3. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

    Authors: William A. Fischer, Joseph J. Eron, Wayne Holman, Myron S. Cohen, Lei Fang, Laura J. Szewczyk, Timothy P. Sheahan, Ralph S. Baric, Katie R. Mollan, Cameron R. Wolfe, Elizabeth R. Duke, Masoud Azizad, Katyna Borroto–Esoda, David A. Wohl, Robert W. Coombs, Amy James Loftis, Paul Alabanza, Felicia Lipansky, Wendy Painter - Science Translational Medicine 2021 cited by 361

  4. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies

    Authors: Jonathan Z. Li, Evgenia Aga, Ronald J. Bosch, Mark A. Pilkinton, Eugène Kroon, Lynsay MacLaren, Michael C. Keefer, Lawrence Fox, Elizabeth Barr, Edward P. Acosta, Jintanat Ananworanich, Robert W. Coombs, John W. Mellors, Alan Landay, Bernard Macatangay, Steven G. Deeks, Rajesh T. Gandhi, Davey M. Smith - Clinical Infectious Diseases 2021 cited by 94

  5. Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

    Authors: Manish C. Choudhary, Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain, Carlee Moser, Michael D. Hughes, Justin Ritz, Ruy M. Ribeiro, Ruian Ke, Joan Dragavon, Arzhang Cyrus Javan, Ajay Nirula, Paul Klekotka, Alexander L. Greninger, Courtney V. Fletcher, Eric S. Daar, David A. Wohl, Joseph J. Eron, Judith S. Currier, Urvi M. Parikh, Scott F. Sieg, Alan S. Perelson, Robert W. Coombs, Davey M. Smith, Jonathan Z. Li, for the ACTIV-2/A5401 Study Team, David R. Smith, Arzhang Cyrus Javan, Mark J Giganti, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott F. Sieg, William A. Fischer, Teresa H. Evering, Rachel Bender Ignacio, Sandra Wagner Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi - Nature Microbiology 2022 cited by 53

  6. Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment

    Authors: Edward M. Connor, Rhoda Sperling, Richard D. Gelber, P.N. Kiselev, Gwendolyn B. Scott, Mary Jo O’Sullivan, Russell VanDyke, Mohammed Bey, William T. Shearer, Robert L. Jacobson, Eleanor Jiménez, Edward H. O'Neill, Brigitte Bazin, Jean-François Delfraissy, Mary Culnane, Robert W. Coombs, Mary Elkins, Jack Moye, Pamela Stratton, James Balsley - New England Journal of Medicine 1994 cited by 3,741

  7. The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion

    Authors: Deborah Donnell, Eric M. Ramos, Connie Celum, Jared M. Baeten, Joan Dragavon, Jordan W. Tappero, Jairam R. Lingappa, Allan Ronald, Kenneth H. Fife, Robert W. Coombs - AIDS 2017 cited by 110

  8. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus

    Authors: Scott Letendre, Huichao Chen, Ashley McKhann, Jhoanna Roa, Alyssa Vecchio, Eric S. Daar, Baiba Berzins, Peter W. Hunt, Christina M. Marra, Thomas Campbell, Robert W. Coombs, Qing Ma, Shobha Swaminathan, Bernard Macatangay, Gene D. Morse, Thomas A. Miller, D. Rusin, Alexander L. Greninger, Belinda Ha, Beverly Alston‐Smith, Kevin Robertson, Robert Paul, Serena Spudich, the A5324 Study Team - Clinical Infectious Diseases 2023 cited by 27

  9. Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

    Authors: Craig W. Hendrix, Ann C. Collier, Michael M. Lederman, Dominique Schols, Richard B. Pollard, Stephen Brown, J. Brooks Jackson, Robert W. Coombs, Marshall J. Glesby, Charles Flexner, Gary Bridger, Karin Badel, R. T. MacFarland, Geoffrey Henson, Gary Calandra - JAIDS Journal of Acquired Immune Deficiency Syndromes 2004 cited by 362

  10. A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

    Authors: Timothy Wilkin, Huichao Chen, Michelle Cespedes, Jorge Leon-Cruz, Catherine Godfrey, Elizabeth Y. Chiao, Barbara Bastow, Jennifer Webster‐Cyriaque, Qinghua Feng, Joan Dragavon, Robert W. Coombs, Rachel M. Presti, Alfred J. Saah, Ross Cranston - Clinical Infectious Diseases 2018 cited by 139

  11. Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine

    Authors: Ann C. Collier, Robert W. Coombs, David Schoenfeld, Roland L. Bassett, Joseph Timpone, Alice Baruch, Michelle Jones, Karen Facey, Caroline C. Whitacre, Vincent McAuliffe, Harvey M. Friedman, Thomas C. Merigan, Richard C. Reichman, Carol J. Hooper, Lawrence Corey - New England Journal of Medicine 1996 cited by 756

  12. Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2

    Authors: Connie Celum, Anna Wald, Jairam R. Lingappa, Amalia Magaret, R.S. Wang, Nelly Mugo, Andrew Mujugira, Jared M. Baeten, James I. Mullins, James P. Hughes, Elizabeth A. Bukusi, Craig R. Cohen, Elly Katabira, Allan Ronald, James Kiarie, Carey Farquhar, Grace John Stewart, Joseph Makhema, Max Essex, Edwin Were, K H Fife, Guy de Bruyn, Glenda Gray, James McIntyre, Rachel Manongi, Saidi Kapiga, David Coetzee, Susan Allen, Mubiana Inambao, Kayitesi Kayitenkore, Etienne Karita, William Kanweka, Sinéad Delany, Helen Rees, Bellington Vwalika, Wendy Stevens, Mical S. Campbell, Katherine K. Thomas, Robert W. Coombs, Rhoda Ashley Morrow, William L. H. Whittington, M. Juliana McElrath, Linda Barnes, Renée Ridzon, Lawrence Corey - New England Journal of Medicine 2010 cited by 526

  13. A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

    Authors: Claire Levy, Sean M. Hughes, Pavitra Roychoudhury, Daniel B. Reeves, Chelsea Amstuz, Haiying Zhu, Meei‐Li Huang, Yulun Wei, Marta E. Bull, Noah A.J. Cassidy, Jan McClure, Lisa M. Frenkel, Mars Stone, Sonia Bakkour, Elizabeth R. Wonderlich, Michael P. Busch, Steven G. Deeks, Joshua T. Schiffer, Robert W. Coombs, Dara A. Lehman, Keith R. Jerome, Florian Hladik - Cell Reports Medicine 2021 cited by 106

  14. Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

    Authors: Kara W Chew, Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs, Justin Ritz, Mark J Giganti, Arzhang Cyrus Javan, Yijia Li, Manish C. Choudhary, Rinki Deo, Carlos Malvestutto, Paul Klekotka, Karen Price, Ajay Nirula, William A. Fischer, Veenu Bala, Ruy M. Ribeiro, Alan S. Perelson, Courtney V. Fletcher, Joseph J. Eron, Judith S. Currier, ACTIV-2/A5401 Study Team, Michael D. Hughes, Davey M. Smith - Nature Communications 2022 cited by 49

  15. Predictors of HIV rebound differ by timing of antiretroviral therapy initiation

    Authors: Jonathan Z. Li, Meghan Melberg, Autumn Kittilson, Mohamed Abdel‐Mohsen, Yijia Li, Evgenia Aga, Ronald J. Bosch, Elizabeth R. Wonderlich, Jennifer Kinslow, Leila B. Giron, Clara Di Germanio, Mark A. Pilkinton, Lynsay MacLaren, Michael C. Keefer, Lawrence K. Fox, Elizabeth Barr, Edward P. Acosta, Jintanat Ananworanich, Robert W. Coombs, John W. Mellors, Steven G. Deeks, Rajesh T. Gandhi, Michael P. Busch, Alan Landay, Bernard Macatangay, Davey M. Smith - JCI Insight 2024 cited by 27

  16. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

    Authors: Ginger Lehrman, Ian B. Hogue, Sarah Palmer, Cheryl Jennings, Celsa A. Spina, Ann Wiegand, Alan Landay, Robert W. Coombs, Douglas D. Richman, John W. Mellors, John M. Coffin, Ronald J. Bosch, David M. Margolis - The Lancet 2005 cited by 511

  17. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

    Authors: Hadega Aamer, Jan McClure, Daisy Ko, Janine Maenza, Ann C. Collier, Robert W. Coombs, James I. Mullins, Lisa M. Frenkel - PLoS Pathogens 2020 cited by 40

  18. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

    Authors: Christina M. Marra, Yu Zhao, David B. Clifford, Scott Letendre, Scott Evans, Katherine Henry, Ronald J. Ellis, Benigno Rodríguez, Robert W. Coombs, Giovanni Schifitto, Justin C. McArthur, Kevin Robertson - AIDS 2009 cited by 348

  19. Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)

    Authors: Ann Duerr, Yunda Huang, Susan Buchbinder, Robert W. Coombs, Jorge Sánchez, Carlos del Rı́o, Martín Casapía, Solano Kaluangila Andrelino Santiago, Peter B. Gilbert, Lawrence Corey, Michael Robertson, for the Step/HVTN 504 Study Team - The Journal of Infectious Diseases 2012 cited by 210

  20. Evidence That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC‐HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068

    Authors: Jeffrey M. Jacobson, R. Pat Bucy, John Spritzler, Michael S. Saag, Joseph J. Eron, Robert W. Coombs, Rui Wang, Lawrence Fox, Victoria A. Johnson, Susan Cu‐Uvin, Susan E. Cohn, Donna Mildvan, Dorothy O’Neill, Jennifer Janik, Lynette Purdue, Deborah K. O’Connor, Christine Di Vita, Ian Frank - The Journal of Infectious Diseases 2006 cited by 103

  21. Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection

    Authors: Randy M. Stalter, Jared M. Baeten, Deborah Donnell, Matthew A. Spinelli, David V. Glidden, Warren C. Rodrigues, Guohong Wang, Michael S. Vincent, Nelly Mugo, Andrew Mujugira, Mark A. Marzinke, Craig W. Hendrix, Monica Gandhi, for the Partners PrEP Study Team, Connie Celum, Jared M. Baeten, Deborah Donnell, Robert W. Coombs, Jairam R. Lingappa, M. Juliana McElrath, Kenneth H. Fife, Edwin Were, Elioda Tumwesigye, Patrick Ndase, Elly Katabira, Elly Katabira, Allan Ronald, Elizabeth A. Bukusi, Craig R. Cohen, Jonathan Wangisi, James D. Campbell, Jordan W. Tappero, James Kiarie, Carey Farquhar, Grace John‐Stewart, Nelly Mugo, Kenneth Ngure, James D. Campbell, Jordan W. Tappero, Jonathan Wangisi - Clinical Infectious Diseases 2020 cited by 21

  22. One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

    Authors: Nikolaus Jilg, Kara W Chew, Mark J Giganti, Eric S. Daar, David A. Wohl, Arzhang Cyrus Javan, Amy Kantor, Carlee Moser, Robert W. Coombs, Gene Neytman, Keila Hoover, Atasi Jana, Phil A. Hart, Alexander L. Greninger, Bob Szurgot, Joseph J. Eron, Judith S. Currier, Michael D. Hughes, Davey M. Smith, Jonathan Z. Li, for the ACTIV-2/A5401 Study Team, Kara W Chew, David R. Smith, Eric S. Daar, David A. Wohl, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan, Michael D. Hughes, Carlee Moser, Mark J Giganti, Justin Ritz, Lara Hosey, Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck, Scott F. Sieg, Jonathan Z. Li, Courtney V. Fletcher, William A. Fischer, Teresa H. Evering, Robert W. Coombs, Rachel Bender Ignacio, Sandra Wagner Cardoso, Katya Corado, Prasanna Jagannathan, Nikolaus Jilg, Alan S. Perelson, Sandy Pillay, Cynthia Riviere, Upinder Singh, Babafemi Taiwo, Joan Gottesman, Matthew Newell, Susan Pedersen, Joan Dragavon, Cheryl Jennings, Brian Greenfelder, William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi, Bob Szurgot - Clinical Infectious Diseases 2023 cited by 19

  23. HIV viral load markers in clinical practice

    Authors: Michael S. Saag, Mark Holodniy, Daniel R. Kuritzkes, William A. O’Brien, Robert W. Coombs, Margaret E. Poscher, Donna M. Jacobsen, George M. Shaw, Douglas D. Richman, Paul A. Volberding - Nature Medicine 1996 cited by 536

  24. Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission

    Authors: Jared M. Baeten, Erin Kahle, Jairam R. Lingappa, Robert W. Coombs, Sinéad Delany‐Moretlwe, Moses Joloba, Nelly Mugo, Anna Wald, Lawrence Corey, Deborah Donnell, Mary S. Campbell, James I. Mullins, Connie Celum - Science Translational Medicine 2011 cited by 296